Citation: | WANG Xue, WANG Yu-he, GAO Shan, HOU Ting-ting, HONG Lei, ZHU Yu-lin, ZHANG Yong. Evaluation and implementation of an antimicrobial stewardship checklist in a respiratory ICU ward in a tertiary teaching hospital[J]. Chinese Journal of General Practice, 2022, 20(10): 1792-1796. doi: 10.16766/j.cnki.issn.1674-4152.002704 |
[1] |
LIU C J. Antibiotic stewardship challenges in an evolving health-care market in China[J]. Lancet Infect Dis, 2021, 21(6): 753-754. doi: 10.1016/S1473-3099(20)30685-X
|
[2] |
WALLEY J D, ZHANG Z T, WEI X L. Antibiotic overuse in China: Call for consolidated efforts to develop antibiotic stewardship programmes[J]. Lancet Infect Dis, 2021, 21(5): 597.
|
[3] |
MESQUITA M N, GODOY L E, KABBOUTT H A, et al. Antibiotic escalation with the inclusion of a checklist in the pediatric intensive care unit[J]. Rev Chilena Infectol, 2020, 37(4): 349-355. doi: 10.4067/S0716-10182020000400349
|
[4] |
齐秀萍, 李小荣, 张国如, 等. 手术抗菌药物使用核查表在规范围术期抗菌药物合理使用中的应用[J]. 重庆医学, 2018, 47(11): 1528-1530, 1533. doi: 10.3969/j.issn.1671-8348.2018.11.026
QI X P, LI X R, ZHANG G R, et al. Application of the checklist for the use of operative antibiotics in regulating the rational use of perioperative antibiotics[J]. Chongqing Medicine, 2018, 47(11): 1528-1530, 1533. doi: 10.3969/j.issn.1671-8348.2018.11.026
|
[5] |
赵士兵, 邹琪, 张超, 等. 重症医学科质量控制核查表的设计及应用研究[J]. 中华危重病急救医学, 2021, 33(4): 466-471. doi: 10.3760/cma.j.cn121430-20210207-00225
ZHAO S B, ZOU Q, ZHANG C, et al. Design and application of Checklist for quality control in intensive care unit[J]. Chinese Critical Care Medicine, 2021, 33(4): 466-471. doi: 10.3760/cma.j.cn121430-20210207-00225
|
[6] |
VAN DAALEN F V, HULSCHER M, MINDERHOUD C, et al. The antibiotic checklist: An observational study of the discrepancy between reported and actually performed checklist items[J]. BMC Infect Dis, 2018, 18(1): 16. doi: 10.1186/s12879-017-2878-7
|
[7] |
RENNERT-MAY E, CHEW D S, CONLY J, et al. Clinical practice guidelines for creating an acute care hospital-based antimicrobial stewardship program: A systematic review[J]. Am J Infect Control, 2019, 47(8): 979-993. doi: 10.1016/j.ajic.2019.02.010
|
[8] |
KISAT M, ZARZAUR B. Antibiotic therapy in the intensive care unit[J]. Surg Clin North Am, 2022, 102(1): 159-167. doi: 10.1016/j.suc.2021.09.007
|
[9] |
TIMSIT J F, BASSETTI M, CREMER O, et al. Rationalizing antimicrobial therapy in the ICU: A narrative review[J]. Intensive Care Med, 2019, 45(2): 172-189. doi: 10.1007/s00134-019-05520-5
|
[10] |
KADRI S S, LAI Y L, WARNER S, et al. Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: A retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals[J]. Lancet Infect Dis, 2021, 21(2): 241-251. doi: 10.1016/S1473-3099(20)30477-1
|
[11] |
CAMPION M, SCULLY G. Antibiotic use in the intensive care unit: Optimization and de-escalation[J]. J Intensive Care Med, 2018, 33(12): 647-655. doi: 10.1177/0885066618762747
|
[12] |
戚智冬, 杨斯博, 李明, 等. 感染的非抗菌药物治疗策略[J]. 中国感染与化疗杂志, 2020, 20(4): 442-446. https://www.cnki.com.cn/Article/CJFDTOTAL-KGHL202004029.htm
QI Z D, YANG S B, LI M, et al. Non-antibiotic strategy for treatment of infection[J]. Chinese Journal of Infection and Chemotherapy, 2020, 20(4): 442-446. https://www.cnki.com.cn/Article/CJFDTOTAL-KGHL202004029.htm
|
[13] |
WALKER A S, WHITE I R, TURNER R M, et al. Personalised randomised controlled trial designs: A new paradigm to define optimal treatments for carbapenem-resistant infections[J]. Lancet Infect Dis, 2021, 21(6): e175-e181. doi: 10.1016/S1473-3099(20)30791-X
|
[14] |
周奋, 金雨虹, 王广芬, 等. 重症监护病房耐碳青霉烯类肠杆菌科细菌感染的危险因素分析[J]. 中华全科医学, 2019, 17(4): 580-582, 648. doi: 10.16766/j.cnki.issn.1674-4152.000740
ZHOU F, JIN Y H, WANG G F, et al. Analysis of risk factors for bacterial infection of Enterobacteriaceae resistant to carbapenem in intensive care unit[J]. Chinese Journal of General Practice, 2019, 17(4): 580-582, 648. doi: 10.16766/j.cnki.issn.1674-4152.000740
|
[15] |
HEFFERNAN A J, SIME F B, SUN J, et al. β-lactam antibiotic versus combined β-lactam antibiotics and single daily dosing regimens of aminoglycosides for treating serious infections: A meta-analysis[J]. Int J Antimicrob Agents, 2020, 55(3): 105839. DOI: 10.1016/j.ijantimicag.2019.10.020.
|
[16] |
GU W, MILLER S, CHIU C Y. Clinical metagenomic next-generation sequencing for pathogen detection[J]. Annu Rev Pathol, 2019, 14(1): 319-338. doi: 10.1146/annurev-pathmechdis-012418-012751
|
[17] |
娄婷叶, 常清利, 张磊, 等. 医院感染主要致病革兰阴性杆菌分布及耐药性分析[J]. 中国医药, 2019, 14(11): 1737-1741. doi: 10.3760/j.issn.1673-4777.2019.11.034
LOU T Y, CHANG Q L, ZHANG L, et al. Distribution and drug resistance of Gram-negative bacilli in nosocomial infection[J]. China Medicine, 2019, 14(11): 1737-1741. doi: 10.3760/j.issn.1673-4777.2019.11.034
|
[18] |
陈绍森, 胡佩村, 邹林, 等. 呼吸内科鲍曼不动杆菌临床特征、耐药性分析及感染与定植的监测[J]. 当代医学, 2021, 27(16): 5-8. https://www.cnki.com.cn/Article/CJFDTOTAL-DDYI202116003.htm
CHEN S S, HU P C, ZOU L, et al. Clinical characteristics, drug resistance, infection and colonization of Acinetobacter baumannii in respiratory medicine[J]. Contemporary Medicine, 2021, 27(16): 5-8. https://www.cnki.com.cn/Article/CJFDTOTAL-DDYI202116003.htm
|
[19] |
HELLYER T, MANTLE T, MCMULLAN R, et al. How to optimise duration of antibiotic treatment in patients with sepsis?[J]. BMJ 2020, 371: m4357. DOI: 10.1136/bmj.m4357.
|
[20] |
MAGALHÃES C, LIMA M, TRIEU-CUOT P, et al. To give or not to give antibiotics is not the only question[J]. Lancet Infect Dis, 2021, 21(7): e191-e201. doi: 10.1016/S1473-3099(20)30602-2
|
[21] |
SPELLBERG B, RICE L B. Duration of antibiotic therapy: Shorter is better[J]. Ann Intern Med, 2019, 171(3): 210-211. doi: 10.7326/M19-1509
|